Top Markets
Coin of the day
Jyong Biotech Ltd. Ordinary Shares Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares

MENS
株式のランク #19258
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the... Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
株価
$2.22
最終同期: 2026-08-25
時価総額
$168.64M
変化(1日)
-0.09%
変化(1年)
-95.58%
TW
取引 Jyong Biotech Ltd. Ordinary Shares (MENS)

カテゴリー

Jyong Biotech Ltd. Ordinary Shares(MENS)の配当利回りの履歴
Jyong Biotech Ltd. Ordinary Shares(銘柄コード: MENS)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Jyong Biotech Ltd. Ordinary Shares(MENS)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)